41 completed, 12 unknown, 5 not yet recruiting, 4 terminated. 65 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 65 | Completed 41, Unknown 12, Not yet recruiting 5, Terminated 4, Recruiting 2, Active not recruiting 1 |
Follow Diabetic Nephropathies: new trials by email Literature Review of Diabetic Nephropathies trials Research Report on Diabetic Nephropathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD Naoxintong Capsule, Placebo - Diabetic Nephropathy | Phase 4 | Not yet recruiting | Chen Xiangmei | 410 | 2027-03-01 | 2026-07-13 |
| Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy Cognitive Behavioral Therapy (CBT), Oral Medication, Topical Medication - Painful Diabetic Neuropathy (PDN), Diabetic Nephropathies | Phase 4 | Not yet recruiting | University of Michigan | 600 | 2026-11-01 | 2026-10-21 |
| Role of Finerenone in African American Veterans With Diabetic Kidney Disease Finerenone 10 MG, Empagliflozin 10 MG - Diabetic Kidney Disease | Phase 4 | Not yet recruiting | Washington D.C. Veterans Affairs Medical Center | 30 | 2026-10-01 | 2026-08-21 |
| Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study Finerenone, Spironolactone (drug) - Heart Failure, Diabetic Kidney Disease | Phase 4 | Not yet recruiting | Hospital de Messejana Dr. Carlos Alberto Studart Gomes | 60 | 2026-04-01 | 2026-05-13 |
| ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases ACE Reno - Hypertensive Nephropathy, Auto Immune Disorders | Phase 4 | Recruiting | Ace Cells Lab Limited | 300 | 2025-09-20 | 2025-09-23 |
| Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy Keluoxin Capsules, Keluoxin Capsule Simulants, Irbesartan - Diabetic Kidney Disease, Diabetic Retinopathy | Phase 4 | Not yet recruiting | Chinese PLA General Hospital | 460 | 2024-10-01 | 2024-10-28 |
| Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes dapagliflozin, ACE inhibitor - Diabetic Kidney Disease, Type 1 Diabetes | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 54 | 2024-07-01 | 2024-08-01 |
| Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy Pirfenidone, Placebo - Diabetic Nephropathies, Type 2 Diabetes | Phase 4 | Completed | Sidrah Lodhi | 60 | 2024-03-10 | 2025-03-11 |
| Mechanism of SGLT2 Inhibition in the Kidney SGLT2 inhibitor - Type 2 Diabetes, Diabetic Kidney Disease | Phase 4 | Recruiting | University of Michigan | 20 | 2024-01-01 | 2026-06-11 |
| DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study Salt-Diet and/or Ertugliflozin, Ertugliflozin 15 mg - Diabetes Mellitus, Diabetic Kidney Disease | Phase 4 | Completed | Amsterdam UMC, location VUmc | 41 | 2023-07-03 | 2026-04-15 |
| Efficacy and Safety of Telmisartan Compared With Losartan telmisartan, Losartan - Diabetic Nephropathies, Hypertension | Phase 4 | Unknown | Chong Kun Dang Pharmaceutical | 98 | 2023-04-19 | 2024-05-28 |
| Basal Plus GLP1-ra on Glycemic Variability in CKD Dulaglutide, Insulin Degludec, Continuous glucose monitor - Diabetes Mellitus, Diabetic Kidney Disease | Phase 4 | Completed | Elaine Chow | 95 | 2022-01-28 | 2024-12-03 |
| Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease Roxadustat - Diabetic Kidney Disease, Anemia | Phase 4 | Completed | Second Xiangya Hospital of Central South University | 124 | 2021-11-02 | 2026-01-26 |
| Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. Ertugliflozin 15 mg - Type 2 Diabetes Mellitus, Diabetic Kidney Disease | Phase 4 | Completed | Amsterdam UMC, location VUmc | 40 | 2020-12-10 | 2023-05-01 |
| Renohemodynamic Effects of Combined empagliflOzin and LosARtan Empagliflozin 10 MG, Losartan 50Mg Tab, Placebo - Diabetes Mellitus, Type 2, Diabetic Kidney Disease | Phase 4 | Completed | Amsterdam UMC, location VUmc | 24 | 2020-11-04 | 2021-10-08 |
| Pentoxifylline in Diabetic Kidney Disease Pentoxifylline, Placebo - Diabetic Kidney Disease | Phase 4 | Active not recruiting | VA Office of Research and Development | 2376 | 2019-11-18 | 2026-11-05 |
| Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes SGLT2 Inhibition - Type 2 Diabetes, Diabetic Nephropathy | Phase 4 | Unknown | Zhongshan Hospital Xiamen University | 70 | 2019-10-15 | 2019-10-21 |
| Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients SGLT2 inhibitor, ACE inhibitor - Diabetic Nephropathies | Phase 4 | Unknown | Nahla H Tohami | 60 | 2018-06-20 | 2020-04-21 |
| Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES EMPA/LINA 10/5 mg QD (n=22), LINA/EMPA 5/10 mg QD (N=22), Gliclazide 30 mg QD/BID (N=22) - Type2 Diabetes | Phase 4 | Unknown | M.H.H. Kramer | 66 | 2017-11-09 | 2022-01-14 |
| Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes sodium bicarbonate - Type 1 Diabetes, Diabetic Nephropathy | Phase 4 | Completed | University of Colorado, Denver | 45 | 2017-01-01 | 2026-06-17 |
Showing 20 of 65. Sign in to see all of them.
Diabetes Mellitus, Type 2 (17) · Diabetes Mellitus (13) · Hypertension (8) · Albuminuria (7) · Kidney Diseases (5) · Proteinuria (5) · Renal Insufficiency, Chronic (5) · Diabetes Mellitus, Type 1 (4) · Cardiovascular Diseases (2) · Diabetes Complications (2) · Hyperkalemia (2) · Kidney Failure, Chronic (2) · Renal Insufficiency (2) · Vascular Diseases (2)
Endocrine System Diseases (65) · Female Urogenital Diseases (65) · Female Urogenital Diseases and Pregnancy Complications (65) · Male Urogenital Diseases (65) · Urogenital Diseases (65) · Urologic Diseases (65) · Diabetes Complications (63) · Kidney Diseases (60) · Diabetes Mellitus (52) · Metabolic Diseases (33) · Nutritional and Metabolic Diseases (33) · Glucose Metabolism Disorders (31) · Pathological Conditions, Signs and Symptoms (17) · Cardiovascular Diseases (12) · Signs and Symptoms (12)
Losartan (5) · Valsartan (5) · Ramipril (4) · Telmisartan (4) · Hydrochlorothiazide (3) · Lisinopril (3) · Spironolactone (3) · empagliflozin (3) · Angiotensin-Converting Enzyme Inhibitors (2) · Aspirin (2) · Cilostazol (2) · Gliclazide (2) · Irbesartan (2) · Linagliptin (2) · Liraglutide (2)
Amsterdam UMC, location VUmc (5) · Boehringer Ingelheim (3) · Peter Rossing (3) · Steno Diabetes Center Copenhagen (3) · Gulhane School of Medicine (2) · M.H.H. Kramer (2) · Novartis (2) · University of Michigan (2) · AHEPA University Hospital (1) · Ace Cells Lab Limited (1) · Assistance Publique - Hôpitaux de Paris (1) · Baker Heart and Diabetes Institute (1) · Chen Xiangmei (1) · Chinese PLA General Hospital (1) · Chinese University of Hong Kong (1)
United States (10) · China (9) · Denmark (9) · Netherlands (9) · South Korea (5) · Australia (3) · Canada (3) · Japan (3) · Switzerland (3) · Brazil (2) · Egypt (2) · France (2) · Italy (2) · Spain (2) · Taiwan (2)
Peter Rossing, MD (2) · Alireza Esteghamati, MD (1) · BeomSeok Kim, M.D, Ph.D (1) · Brian Callaghan, MD (1) · D.S Choi, MD, PhD (1) · Daniel van Raalte, MD PhD (1) · David J Leehey (1) · David ZI Cherney, MD, PhD (1) · Dr. Alaa Abdelkarim M Fouad, MRCPUK SEC (1) · Dr. Gudrun Caspar-Bell, MD (1) · Edmund J Lewis, MD (1) · Erling B Pedersen, Professor (1)
PMID 38682786, PMID 35224730, PMID 38449081, PMID 38770818, PMID 39963952, PMID 41665872, PMID 11128341, PMID 16123474, PMID 16316360, PMID 18496508, PMID 20413516, PMID 20966122, PMID 22792314, PMID 22981148, PMID 22995802, PMID 24159603, PMID 24866870, PMID 25186534, PMID 27733159, PMID 27753201, PMID 28341782, PMID 28408434, PMID 28449402, PMID 31816432, PMID 32200854, PMID 32340841, PMID 32516291, PMID 32900785, PMID 33107592, PMID 33205810, PMID 34271948, PMID 34400461, PMID 35221224, PMID 35322793, PMID 35998283, PMID 36127497, PMID 36342964, PMID 36344978, PMID 37171199, PMID 37752566, PMID 37916745, PMID 38365853, PMID 39434255, PMID 42216096, PMID 42911768
2015 (2), 2009 (1), 2014 (1)